ArticleCureus2025
Assessment of Liver Enzymes and the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) Among Information Technology (IT) Professionals.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNon-alcoholic fatty liver disease (NAFLD) is a growing public health concern, particularly among individuals with sedentary occupations. Liver enzyme alterations are often early indicators of hepatic steatosis. The information technology (IT) workforce, due to prolonged screen time and limited physical activity, may be particularly vulnerable to NAFLD.
objectiveTo assess the prevalence of NAFLD and liver enzyme abnormalities (alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transferase (GGT)) among IT professionals and to explore associations with lifestyle and metabolic parameters.
methodsThis cross-sectional observational study included 250 IT professionals aged between 25 and 55 years from a tertiary care setting. Data were collected using structured questionnaires, anthropometric assessments, liver function tests (LFTs), and abdominal ultrasonography. Multivariate logistic regression was used to identify independent predictors of NAFLD.
resultsThe mean age of participants was 36.4 ± 6.8 years, with 172 males (68.8%) and 78 females (31.2%). NAFLD was identified in 92 participants (36.8%) via ultrasonography. Elevated ALT levels were observed in 78 participants (31.2%), elevated AST in 52 participants (20.8%), and elevated GGT in 61 participants (24.4%). Among those with NAFLD (n=92), mean BMI was 29.1 kg/m² compared to 26.1 kg/m² in those without NAFLD (p<0.001). Similarly, mean ALT levels were higher in the NAFLD group (50.2 U/L vs. 36.1 U/L, p<0.001). Multivariate analysis identified BMI ≥27 kg/m² (n=143, 57.2%), elevated ALT (n=78, 31.2%), elevated GGT (n=61, 24.4%), and sedentary lifestyle (n=161, 64.4%) as independent predictors of NAFLD.
conclusionThe findings of this study underscore a significant presence of NAFLD and liver enzyme elevations among individuals working in sedentary professional environments, such as the IT sector. The observed associations with modifiable lifestyle factors, particularly physical inactivity and elevated body mass, suggest a pressing need for routine metabolic and hepatic health assessments in such occupational groups. Early identification, coupled with targeted lifestyle modification strategies, holds the potential to mitigate the long-term health risks associated with NAFLD and improve overall workforce well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.